BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shares fell 5.5% during trading on Monday following insider selling activity. The company traded as low as $32.48 and last traded at $32.33.
The adrenal autoimmune process is made evident by the apperance of circulating autoantibodies against the steroidogenic enzyme 21-hydroxylase. Detection of 21-hydroxylase in patients with ...
Similarly to other organ-specific autoantibodies, 21OHAb have no major pathogenic role in the development of adrenal insufficiency ... of circulating 21-hydroxylase autoantibodies, which are ...
Use of DHEAS testing alongside baseline cortisol testing improved diagnostic accuracy of adrenal insufficiency ... oral estrogen use, or congenital adrenal hyperplasia. The CST protocol involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback